BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32065287)

  • 1. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis.
    van 't Sant I; Engbersen MP; Bhairosing PA; Lambregts DMJ; Beets-Tan RGH; van Driel WJ; Aalbers AGJ; Kok NFM; Lahaye MJ
    Eur Radiol; 2020 Jun; 30(6):3101-3112. PubMed ID: 32065287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer.
    Roze JF; Hoogendam JP; van de Wetering FT; Spijker R; Verleye L; Vlayen J; Veldhuis WB; Scholten RJ; Zweemer RP
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012567. PubMed ID: 30298516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
    Huang SM; Yin L; Yue JL; Li YF; Yang Y; Lin ZC
    Medicine (Baltimore); 2018 Dec; 97(50):e13344. PubMed ID: 30557983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body MRI with diffusion-weighted imaging as an adjunct to
    Willemse JRJ; Lahaye MJ; Kok NFM; Grotenhuis BA; Aalbers AGJ; Beets GL; Rijsemus C; Maas M; van Golen LW; Beets-Tan RGH; Lambregts DMJ
    Colorectal Dis; 2024 Feb; 26(2):290-299. PubMed ID: 38145899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
    Mikkelsen MS; Petersen LK; Blaakaer J; Marinovskij E; Rosenkilde M; Andersen G; Bouchelouche K; Iversen LH
    Eur J Surg Oncol; 2021 Aug; 47(8):2134-2141. PubMed ID: 33812768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis.
    Laghi A; Bellini D; Rengo M; Accarpio F; Caruso D; Biacchi D; Di Giorgio A; Sammartino P
    Radiol Med; 2017 Jan; 122(1):1-15. PubMed ID: 27647163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
    Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
    Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis.
    Wu LM; Hu J; Gu HY; Hua J; Xu JR
    Eur J Cancer; 2013 Feb; 49(3):572-84. PubMed ID: 23000072
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS
    Ann Nucl Med; 2019 May; 33(5):351-361. PubMed ID: 30877561
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MRI versus FDG-PET/CT for diagnosing pancreatic cancer: an indirect comparison meta-analysis.
    Que R; Chen Y; Tao Z; Ge B; Li M; Fu Z; Li Y
    Acta Radiol; 2020 Nov; 61(11):1473-1483. PubMed ID: 32148066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies.
    Liu B; Gao S; Li S
    Gynecol Obstet Invest; 2017; 82(3):209-222. PubMed ID: 28183074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
    Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
    Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect comparison of the diagnostic performance of
    Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
    BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis.
    Li X; Wang L; Guo P; Sun Q; Zhang Y; Chen C; Zhang Y
    Ann Nucl Med; 2023 Oct; 37(10):541-550. PubMed ID: 37422857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
    Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
    Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of [
    Hong SB; Choi SH; Kim KW; Park SH; Kim SY; Lee SJ; Lee SS; Byun JH; Lee MG
    Eur Radiol; 2019 Jul; 29(7):3553-3563. PubMed ID: 30715585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.